Improving Emergency Department Testing for Deep Vein Thrombosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

458 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-01

Study Completion Date

2025-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This observational study will use a new way to test for deep vein thrombosis (DVT) of the leg. A DVT is a blood clot in the leg and is a medical problem that can cause swelling, pain, and redness. If the blood clot is not treated, it can cause more serious, long-term effects, and occasionally lead to death.

The main questions the study aims to answer are:

1. How safe is our new blood clot testing method?
2. How efficient is our new blood clot testing method?

The study will be run in the emergency department and urgent care centre in Kingston, Ontario. Patients who are tested for a DVT in the leg can be included in the study. Researchers follow the patient through chart review to make sure the new system is safe and efficient.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Designer D-dimer Deep Vein Thrombosis Diagnosis (4D) Study

NCT02038530

Suspected Deep Vein Thrombosis

COMPLETED

Selective D-Dimer Testing Compared With Uniform D-Dimer Testing in the Diagnosis of Deep Vein Thrombosis (SELECT)

NCT00157677

Deep Vein Thrombosis

COMPLETED PHASE3

Single Session Percutaneous Mechanical Thrombectomy for the Treatment of Ilio-femoral Deep Vein Thrombosis: A Preliminary Evaluation

NCT02066597

Deep Vein Thrombosis Venous Thromboembolism

TERMINATED PHASE2

MDA D-Dimer / Recurrent DVT Study

NCT00157599

Deep Vein Thrombosis

COMPLETED NA

Targeted Metabolic Profiling in Deep Vein Thrombosis

NCT04096755

Deep Vein Thrombosis

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Deep Vein Thrombosis (DVT)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- emergency physician decides to test for DVT of the lower limb.

Exclusion Criteria

* \<18 years of age;
* tested for DVT without using the ToDay algorithm at the index visit;
* D-dimer level is known before ToDay item assessment;
* a new indication for anticoagulation at the emergency department assessment (other than DVT) in a patient not previously prescribed an anticoagulant;
* a history of prior lower limb DVT, where there is no access to baseline ultrasound imaging;
* suspected of having a pulmonary embolism;
* has previously participated in this study;
* has previously opted out of all research at hospital site;
* left the emergency department or urgent care centre against medical advice;
* D-dimer was ordered prior to initial physician assessment;
* imaging for DVT or pulmonary embolism within the previous 30 days;
* transferred from another hospital organization.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No